Mahindra Lifespace Developers Ltd., Bank of India, Rail Vikas Nigam Ltd., Container Corp. and Cipla Ltd. are some of the stocks that will be on the radar on Wednesday. Container Corp: The company ...

So, within the generic companies, from the US point of view, Cipla delivered a very good set of results supported by the ...

Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...

Healthguard Distribution, the full-fledged pharmacy distribution arm of Sunshine Holdings PLC, recently entered into a strategic partnership with Breathe Free Lanka Private Ltd, a wholly owned ...

Here’s a quick look at stocks likely to be in focus in today's trade. NHPC: State-owned NHPC Ltd reported a 52.5 percent year ...

Bajaj Auto is gearing up to enter the domestic e-rickshaw segment by the end of this fiscal to tap a 'sizable opportunity' in ...

As per the brokerage firm, Cipla’s Q3FY25 exceeded expectations, mostly driven by a healthier product mix and lower research and development spending. The company reported a 7.1% YoY revenue ...

Cipla Q3 results review: The shares of the third largest pharmaceutical firm Cipla rose 2.44 per cent at Rs 1,454.20 a piece on the BSE intraday after the company delivered a solid quarterly earnings ...

Q3 Earnings, Results 2025: Companies like TVS Motor, Hindustan Zinc, Hyundai Motor, GMR Airports, Bajaj Auto, Cipla, Piramal Pharma ... Ltd., the parent company of travel aggregator Ixigo ...

Cipla's stock settled 2.2% higher at ₹1,427 on Tuesday on the National Stock Exchange. The company expects to launch its breast cancer drug Abraxane, which was originally slated for a rollout in ...

Shares of drugmaker Cipla Ltd. surged to the day's high, gaining as much as 4% after the company's December quarter results. The results were a beat across parameters.

That more than made up for a 1% drop in sales in North America, Cipla's second-biggest market, and helped the company's total revenue climb 7.1% to 70.73 billion rupees, surpassing market ...